DAVID PORTER: Open Payments
NPI 1386139285 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,708 in 43 payments from 14 companies in 2025. Trend: 2023 $597 · 2024 $2,548 · 2025 $3,708
Consulting: $2,849Food & beverage: $747Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $2,916 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $170 |
| ABBVIE INC. | 9 | $135 |
| Teva Pharmaceuticals USA, Inc. | 2 | $129 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Alkermes, Inc. | 2 | $33 |
| Edwards Lifesciences Corporation | 1 | $31 |
Products named: REJOYN, CAPLYTA, VRAYLAR, REXULTI, Auvelity, INGREZZA, COBENFY, ARISTADA.
Industry payments across NY — which companies pay providers there.
